Determinants that may be involved in virulence and disease in Campylobacter jejuni

Journal of Food Safety

Volumn 16, Issue 2, 1996, Pages 105-139

  Smith, James L ^a  

^a EASTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029976281     PISSN: 01496085     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-4565.1996.tb00154.x     Document Type: Article

References (199)

1. ABBAS, A.K., LICHTMAN, A.H. and POBER, J.S. 1991. Cellular and Molecular Immunology. W.B. Saunders Co., Philadelphia, PA.
2. ABE, J. et al. 1993. Evidence of superantigen production by Yersinia pseudotuberculosis. J. Immunol. 151, 4183-4188.
3. AGUERO-ROSENFELD, M.E., YANG, X.-H. and NACHAMKIN, I. 1990. Infection of adult Syrian hamsters with flagellar variants of Campylobacter jejuni. Infect. Immun. 58, 2214-2219.
4. AKHTAR, S.Q. and HUQ, F. 1989. Effect of Campylobacter jejuni extracts and culture supernatants on cell culture. J. Trop. Med. Hyg. 92, 80-85.
5. ANON 1994. Outbreak of Salmonella enteritidis associated with nationally distributed ice cream products - Minnesota, South Dakota, and Wisconsin, 1994. Morb. Mort. Week. Rept. 43, 740-741.
6. ARIMI, S.M., PARK, R.W.A. and FRICKER, C.R. 1990. Study of haemolytic activity of some Campylobacter spp. on blood agar plates. J. Appl. Bacteriol. 69, 384-389.
7. ASPINALL, G.O., McDONALD, A.G., PANG, H., KURJANECZYK, L.A. and PENNER, J.L. 1994a. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33, 241-249.
8. ASPINALL, G.O., FUIJIMOTO, S., McDONALD, A.G., PANG, H., KURJANCZYK, L.A. and PENNER, J.L. 1994b. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62, 2122-2125.
9. BABAKHANI, F.K., BRADLEY, G.A. and JOENS, L.A. 1993. Newborn piglet model for campylobacteriosis. Infect. Immun. 61, 3466-3475.
10. BABAKHANI, F.K. and JOENS, L.A. 1993. Primary swine intestinal cells as a model for studying Campylobacter jejuni invasiveness. Infect. Immun. 61, 2723-2726.
11. BAIG, B.H., WACHSMUTH, I.K. and MORSE, S.R. 1986. Utilization of exogenous siderophores by Campylobacter species. J. Clin. Microbiol. 23, 431-433.
12. BARCLAY, R. 1985. The role of iron in infection. Med. Lab. Sci. 42, 166-177.
13. BELBOURI, A. and MEGRAUD, F. 1988. Enterotoxin-like activity produced by Campylobacter jejuni and Campylobacter coli isolated from patients and healthy controls in Algeria. FEMS Microbiol. Lett. 57, 25-28.
14. BLACK, R.E., LEVINE, M.M., CLEMENTS, M.L., HUGHES, T.P. and BLASER, M.J. 1988. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis. 157, 472-479.
15. BOK, H.E., GREEFF, A.S. and CREWE-BROWN, H.H. 1991. Incidence of toxigenic Campylobacter strains in South Africa. J. Clin. Microbiol. 29, 1262-1264.
16. BOUZARI, S. and VARGHESE, A. 1990. Cytolethal distending toxin (CLDT) production by enteropathogenic Escherichia coli (EPEC). FEMS Microbiol. Lett. 71, 193-198.
17. BOUZARI, S. and VARGHESE, A. 1992. In vitro adherence property of cytolethal distending toxin (CLDT) producing EPEC strains and effect of the toxin on rabbit intestine. Microbial Pathogen. 12, 153-157.
18. BUCHMEIER, N. A. and HEFFRON, F. 1990. Induction of Salmonella stress proteins upon infection of macrophages. Science 248, 730-732.
19. BUKHOLM, G. and KAPPERUD, G. 1987. Expression of Campylobacter jejuni invasiveness in cell cultures coinfected with other bacteria. Infect. Immun. 55, 2816-2821.
20. CALDERWOOD, S.B. and MEKALANOS, J.J. 1987. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J. Bacteriol. 169, 4759-4764.
21. CALDWELL, M.B., GUERRY, P., LEE, E.C., BURANS, J.P. and WALKER, R.L. 1985. Reversible expression of flagella in Campylobacter jejuni. Infect. Immun. 50, 941-943.
22. CALVA, E., TORRES, J., VAZQUEZ, M., ANGELES, V., VEGA, H. de la and RUIZ-PALACIOS, G.M. 1989. Campylobacter jejuni chromosomal segments that hybridize to Vibrio cholerae and Escherichia coli LT enterotoxin genes. Gene 75, 243-251.
23. CHAN, V.L., LOUIE, H. and BINGHAM, H.L. 1995. Cloning and transcription regulation of the ferric uptake regulatory gene of Campylobacter jejuni TGH9011. Gene 164, 25-31.
24. CHIBA, A., KUSUNOKI, S., SHIMIZU, T. and KANAZAWA, I. 1992. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31, 677-679.
25. CINCO, M., BANFI, E., RUARO, E., CREVATIN, D. and CROTTI, D. 1984. Evidence for L-fucose (6-deoxy-L-galactopyranose)-mediated adherence of Campylobacter spp. to epithelial cells. FEMS Microbiol. Lett. 21, 347-351.
26. CLERICI, M. and SHEARER, G.M. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15, 575-581.
27. COLLINS, S., O'LOUGHLIN, E., O'ROURKE, J., LI, A., LEE, A. and HOWDEN, M. 1992. A cytotonic cholera toxin-like protein produced by Campylobacter jejuni. Compar. Biochem. Physiol., part B 103B, 299-303.
28. COWDEN, J. 1992. Campylobacter: epidemiological paradoxes. Br. Med. J. 305, 132-133.
29. DAIKOKU, T., KAWAGUCHI, M., TAKAMA, K. and SUZUKI, S. 1990. Partial purification and characterization of the enterotoxin produced by Campylobacter jejuni. Infect. Immun. 55, 2414-2419.
30. DE MELO, M.A. and PECHERE, J.-C. 1990. Identification of Campylobacter jejuni surface proteins that bind to eucaryotic cells in vitro. Infect. Immun. 58, 1749-1756.
31. DONNENBERG, M.S., DONOHUE-ROLFE, A. and KEUSCH, G.T. 1989. Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. J. Infect. Dis. 160, 452-459.
32. DONNENBERG, M.S. and KAPER. J.B. 1992. Enteropathogenic Escherichia coli. Infect. Immun. 60, 3953-3961.
33. DONOWITZ, M. 1985. Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway. Gastroenterology 88, 580-587.
34. ENSGRABER, M. and LOOS, M. 1992. A 66-kilodalton heat shock protein of Salmonella typhimurium is responsible for binding of the bacterium to intestinal mucus. Infect. Immun. 60, 3072-3078.
35. 2, and cyclic AMP in Campylobacter jejuni-induced intestinal fluid secretion. Infect. Immun. 61, 4885-4887.
36. EVEREST, P.H. et al. 1993b. Pathological changes in the rabbit ileal loop model caused by Campylobacter jejuni from human colitis. J. Med. Microbiol. 38, 316-321.
37. FAUCHERE, J.-L., KERVELLA, M., ROSENAU, A., MOHANNA, K. and VERON, M. 1989. Adhesion to HeLa cells of Campylobacter jejuni and C. coli outer membrane components. Res. Microbiol. 140, 379-392.
38. FAUCHERE, J.-L., KERVELLA, M., ROSENAU, A., PAGES, J.M. and FENDRI, C. 1992. In vitro study of virulence factors of enteric Campylobacter spp., In Campylobacter jejuni: Current Status and Future Trends (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.), pp. 168-175, Am. Soc. Microbiol, Washington, DC.
39. FERRERO, R.L. and LEE, A. 1988. Motility of Campylobacter jejuni in a viscous environment: comparison with conventional rod-shaped bacteria. J. Gen. Microbiol. 134, 53-59.
40. FIELD, L.H., HEADLEY, V.L., PAYNE, S.M. and BERRY, L.J. 1986. Influence of iron on growth, morphology, outer membrane protein composition, and synthesis of siderophores in Campylobacter jejuni. Infect. Immun. 54, 126-132.
41. FIELD, L.H., UNDERWOOD, J.L., PAYNE, S.M. and BERRY, L.J. 1993. Characteristics of an avirulent Campylobacter jejuni strain and its virulence-enhanced variants. J. Med. Microbiol. 35, 293-300.
42. FINLAY, B.B. and FALKOW, S. 1990. Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J. Infect. Dis. 162, 1096-1106.
43. FLORIN, I. and ANTILLON, F. 1992. Production of enterotoxin and cytotoxin in Campylobacter jejuni isolated in Costa Rica. J. Med. Microbiol. 37, 22-29.
44. FLUGEL, A. et al. 1994. Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin. J. Biol. Chem. 269, 29732-29738.
45. FOX, J.G. 1992. In vivo models of enteric campylobacteriosis: natural and experimental infections, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 131-138, Am. Soc. Microbiol, Washington, DC.
46. FUJIMOTO, S. and AMAKO, K. 1990. Guillain-Barré syndrome and Campylobacter jejuni infection. Lancet 335, 1350.
47. FUKUTA, S., MAGNANI, J.L., TWIDDY, E.M., HOLMES, R.K. and GINSBERG, V. 1988. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins Lth-I, Lt-IIa and Lt-IIb. Infect. Immun. 56, 1748-1751.
48. GAEDE, K.I. and HEESEMANN, J. 1995. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats. Infect. Immun. 63, 714-719.
49. GASTON, J.S.H. 1994. The role of infection in inflammatory arthritis. Quart. J. Med. 87, 647-651.
50. GASTON, J.S.H. et al. 1989. Synovial T lymphocytes recognition of organisms that trigger reactive arthritis. Clin. Exp. Immunol. 76, 348-353.
51. GEORGE, H.A., HOFFMAN, P.S., SMIBERT, R.M. and KRIEG, N.R. 1978. Improved media for growth and aerotolerance of Campylobacter fetus. J. Clin. Microbiol. 8, 36-41.
52. GLENN-CALVO, E., BAR, W. and FROSCH, M. 1992. Isolation and characterization of the flagellar hook of Campylobacter jejuni. FEMS Microbiol. Lett. 123, 299-304.
53. GOOSSENS, H., BUTZLER, J.-P. and TAKEDA, Y. 1985. Demonstration of cholera-like enterotoxin production by Campylobacter jejuni. FEMS Microbiol. Lett. 29, 73-76.
54. GRANFORS, K. 1989. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. New Eng. J. Med. 320, 216-221.
55. GRANFORS, K. 1990. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 335, 685-688.
56. GRANFORS, K., JALKANEN, S., TOIVANEN, P., KOSKI, J. and LINDBERG, A.A. 1992. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J. Rheum. 19, 500.
57. GRANT, C.C.R., KONKEL, M.E., CIEPLAK, W. and TOMPKINS, L.S. 1993. Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. Infect. Immun. 61, 1764-1771.
58. GRIPENBERG-LERCHE, C., SKURNIK, M., ZHANG, L., SODERSTROM, K.-O. and TOIVANEN, P. 1994. Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect. Immun. 62, 5568-5575.
59. GRUTZKAU, A., HANSKI, C., HAHN, H. and RIECKEN, E.O. 1990. Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31, 1011-1015.
60. GUERINOT, M.L. 1994. Microbial iron transport. Ann. Rev. Microbiol. 48, 743-772.
61. GUERRANT, R.L., FANG, G., PENNIE, R.A. and PEARSON, R.D. 1992. In vitro models for studying Campylobacter jejuni infections, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 160-167, Am. Soc. Microbiol, Washington, DC.
62. GUERRANT, R.L., WANKE, C.A., PENNIE, R.A., BARRETT, L.J., LIMA, A.A.M. and O'BRIEN, A.D. 1987. Production of a unique cytotoxin by Campylobacter jejuni. Infect. Immun. 55, 2526-2530.
63. GUERRY, P., ALM, R.A., POWER, M.E. and TRUST, T.J. 1992. Molecular and structural analysis of Campylobacter flagellin, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 267-281, Am. Soc. Microbiol, Washington, DC.
64. GUTH, B.E.C., GIRALDI, R., GOMES, T.A.T. and MARQUES, L.R.M. 1994. Survey of cytotoxin production among Escherichia coli strains characterized as enteropathogenic (EPEC) by serotyping and presence of EPEC adherence factor (EAF) sequences. Can. J. Microbiol. 40, 341-344.
65. HANSKI, C. et al. 1989. Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype 08 with intestinal mucosa during experimental enteritis. Infect. Immun. 57, 671-678.
66. HARRIS, L.A., LOGAN, S.M., GUERRY, P. and TRUST, T.J. 1987. Antigenic variation of Campylobacter flagella. J. Bacteriol. 169, 5066-5071.
67. HERMANN, E. 1993. T cells in reactive arthritis. APMIS 101, 177-186.
68. HERMANN, E. et al. 1991. Synovial fluid-derived Yersinia-rezctive T cells responding to human 64-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur. J. Immunol. 21, 2139-2143.
69. HOFFMAN, P.S., KRIEG, N.R. and SMIBERT, R.M. 1979. Studies of the microaerophilic nature of Campylobacter fetus subsp. jejuni. I. Physiological aspects of enhanced aerotolerance. Can. J. Microbiol. 25, 1-7.
70. IMBERTI, L., SOTTINI, A., BETTINARDI, A., MAZZA, C. and PRIMI, D. 1992. The paradoxical paradigm of superantigen activity. J. Immunol. Res. 4, 86-98.
71. JOHNSON, W.M. and LIOR, H. 1986. Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J. Clin. Microbiol. 24, 275-281.
72. JOHNSON, W.M. and LIOR, H. 1987a. Production of Shiga toxin and a cytolethal distending toxin (CLDT) by serogroups of Shigella spp. FEMS Microbiol. Lett. 48, 235-238.
73. JOHNSON, W.M. and LIOR, H. 1987b. Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol. Lett. 43, 19-23.
74. JOHNSON, W.M. and LIOR, H. 1988a. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microbial Pathogen. 4, 115-126.
75. JOHNSON, W.M. and LIOR, H. 1988b. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microbial Pathogen. 4, 103-113.
76. KAZMI, S.U., ROBERSON, B.S. and STERN, N.J. 1984. Animal-passed, virulence-enhanced Campylobacter jejuni causes enteritis in neonatal mice. Curr. Microbiol. 11, 159-164.
77. KETLEY, J.M. 1995 Virulence of Campylobacter species: a molecular genetic approach. J. Med. Microbiol. 42, 312-327.
78. KHAWAJA, R., NEOTE, K., BINGHAM, H.L., PENNER, J.L. and CHAN, V.L. 1992. Cloning and sequence analysis of the flagellin gene of Campylobacter jejuni TGH9011. Curr. Microbiol. 24, 213-221.
79. KLIPSTEIN, F.A. and ENGERT, R.F. 1984a. Properties of crude Campylobacter jejuni heat-labile enterotoxin. Infect. Immun. 45, 314-319.
80. KLIPSTEIN, F.A. and ENGERT, R.F. 1984b. Purification of Campylobacter jejuni enterotoxin. Lancet i, 1123-1124.
81. KLIPSTEIN, F.A. and ENGERT, R.F. 1985. Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins. Infect. Immun. 48, 629-633.
82. KLIPSTEIN, F.A., ENGERT, R.F. and SHORT, H.R. 1986. Enzyme-linked immunosorbent assays for virulence properties of Campylobacter jejuni clinical isolates. J. Clin. Microbiol. 23, 1039-1043.
83. KLIPSTEIN, F.A., ENGERT, R.F., SHORT, H. and SCHENK, E. 1985. Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations. Infect. Immun. 50, 43-49.
84. KOHBATA, S., YOKOYAMA, H. and YABUUCHI, E. 1986. Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study. Microbiol. Immunol. 30, 1225-1237.
85. KONKEL, M.E., BABAKHANI, F. and JOENS, L.A. 1990. Invasion-related antigens of Campylobacter jejuni. J. Infect. Dis. 162, 888-895.
86. KONKEL, M.E. and CIEPLAK, W. 1992. Altered synthetic response of Campylobacter jejuni to cocultivation with human epithelial cells is associated with enhanced internalization. Infect. Immun. 60, 4945-4949.
87. KONKEL, M.E. and JOENS, L.A. 1989. Adhesion to and invasion of HEp-2 cells by Campylobacter spp. Infect. Immun. 57, 2984-2900.
88. KONKEL, M.E., LOBERT, Y. and CIEPAK, W. 1992a. Examination of multiple isolates of Campylobacter jejuni for evidence of cholera toxin-like activity, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 193-198, Am. Soc. Microbiol, Washington, DC.
89. KONKEL, M.E., MEAD, D.J., HAYES, S.F. and CIEPLAK, W. 1992b. Translocation of Campylobacter jejuni across human polarized epithelial cell monolayer cultures. J. Infect. Dis. 166, 308-315.
90. LAHESMAA, R., SHANAFELT, M.-C., STEINMAN, L. and PELTZ, G. 1994. Immunopathogenesis of human inflammatory arthritis: lessons from Lyme and reactive arthritis. J. Infect. Dis. 170, 978-985.
91. LAHESMAA, R. et al. 1992. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J. Immunol. 148, 3079-3085.
92. LEE, A., O'ROURKE, J.I., BARRINGTON, P.J. and TRUST, T.J. 1986. Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model. Infect. Immun. 51, 536-546.
93. LINDBLOM, G.-B., KAIJSER, B. and SJOGREN, E. 1989. Enterotoxin production and serogroups of Campylobacter jejuni and Campylobacter coli from patients with diarrhea and from healthy laying hens. J. Clin. Microbiol. 27, 1272-1276.
94. LITWIN, C.M. and CALDERWOOD, S.C. 1993. Role of iron regulation of virulence genes. Clin. Microbiol. Rev. 6, 137-149.
95. LOGAN, S.M., TRUST, T.J. and GUERRY, P. 1989. Evidence for posttranslational modification and gene duplication of Campylobacter flagellin. J. Bacteriol. 171, 3031-3038.
96. McCARDELL, B.A., MADDEN, J.M. and LEE, E.C. 1984. Campylobacter jejuni and Campylobacter coli production of a cytotonic toxin immunologically similar to cholera toxin. J. Food Prot. 47, 943-949.
97. McCARDELL, B.A., MADDEN, J.M. and STANFIELD, J.T. 1986. Effect of iron concentration on toxin production in Campylobacter jejuni and Campylobacter coli. Can. J. Microbiol. 32, 395-401.
98. McSWEEGAN, E., BURR, D.H. and WALKER, R.I. 1987. Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells. Infect. Immun. 55, 1431-1435.
99. McSWEEGAN, E. and WALKER, R.I. 1986. Identification and characterization of two Campylobacter jejuni adhesions for cellular and mucous substrates. Infect. Immun. 53, 141-148.
100. MAHAJAN, S. and RODGERS, F.G. 1990. Isolation, characterization, and host-cell-binding properties of cytotoxins from Campylobacter jejuni. J. Clin. Microbiol. 28, 1314-1320.
101. MANNINEN, K.I., PRESCOTT, J.F. and DOHOO, I.R. 1982. Pathogenicity of Campylobacter jejuni isolates from animals and humans. Infect. Immun. 38, 46-52.
102. MATHAN, V.I., RAJAN, D.P., KLIPSTEIN, F.A. and ENGERT, R.F. 1984. Enterotoxigenic Campylobacter jejuni among children in South India. Lancet ii, 981.
103. MEINERSMANN, R.J., STERN, N.J. and BLANKENSHIP, L.C. 1990. Antigenic differences incongenic chicken-colonizing and noncolonizing strains of Campylobacter jejuni. Curr. Microbiol. 21, 17-21.
104. MIETZNER, T.A. and MORSE, S.A. 1994. The role of iron-binding proteins in the survival of pathogenic bacteria. Ann. Rev. Nutr. 14, 471-493.
105. MISAWA, N., OHNISHI, T., ITOH, K. and TAKAHASHI, E. 1994. Development of a tissue culture assay system for Campylobacter jejuni cytotoxin and the influence of culture conditions on cytotoxin production. J. Med. Microbiol. 41, 224-230.
106. MIZUNO, K., TAKAMA, K. and SUZUKI, S. 1994. Characteristics of cytotoxin produced by Campylobacter jejuni strains. Microbios 78, 215-218.
107. MOORE, M.A., BLASER, M.J., PEREZ-PEREZ, G.I. and O'BRIEN, A.D. 1988. Production of a Shiga-like cytotoxin by Campylobacter. Microbial Pathogen. 4, 455-462.
108. MOROOKA, T., UMEDA, A. and AMAKO, K. 1985. Motility as intestinal colonization factor for Campylobacter jejuni. J. Gen. Microbiol. 131, 1973-1980.
109. NACHAMKIN, I., YANG, X.-H. and STERN, N.J. 1993. Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis of flagellar mutants. Appl. Environ. Microbiol. 59, 1269-1273.
110. NEWELL, D.G., MCBRIDE, H. and DOLBY, J.M. 1985. Investigations on the role of flagella in the colonization of infant mice with Campylobacter jejuni and attachment of Campylobacter jejuni to human epithelial cell lines. J. Hyg., Camb. 95, 217-227.
111. NIEDERHOFFER, E.C., NARANJO, C.M., BRADLEY, K.L. and FEE, J.A. 1990. Control of Escherichia coli superoxide dismutase (sodA and sodB) genes by the ferric uptake regulation (fur) locus. J. Bacteriol. 172, 1930-1938.
112. NUIJTEN, P.J.M., ASTEN, F.J.A.M. van, GAASTRA, W. and ZEIJST, B.A.M. van der 1990. Structural and functional analysis of two Campylobacter jejuni flagellin genes. J. Biol. Chem. 265, 17798-17804.
113. NUIJTEN, P.J.M., BLEUMINK-PLUYM, N.M.C., GAASTRA, W. and ZEIJST, B. A. M. van der 1989. Flagellin expression in Campylobacter jejuni is regulated at the transcriptional level. Infect. Immun. 57, 1084-1087.
114. NUIJTEN, P.J.M., MARQUEZ-MAGANA, L. and ZEIJST, B.A.M. van der. 1995. Analysis of flagellin gene expression in flagellar phase variants of Campylobacter jejuni 81116. Antonie van Leeuwenhoek 67, 377-383.
115. NUIJTEN, P.J.M., WASSENAAR, T.M., NEWELL, D.G. and ZEIJST, B.A.M. van der 1992. Molecular characterization and analysis of Campylobacter jejuni flagellin genes and proteins, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 282-296, Am. Soc. Microbiol, Washington, DC.
116. NUIJTEN, P.J.M., ZEIJST, B.A.M. van der and NEWELL, D.G. 1991. Localization of immunogenic regions on the flagellin proteins of Campylobacter jejuni 81116. Infect. Immun. 59, 1100-1105.
117. OELSCHLAEGER, T.A., GUERRY, P. and KOPECKO, D.J. 1993. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc. Natl. Acad. Sci. USA 90, 6884-6888.
118. O'GARRA, A. and MURPHY, K. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opinions Immunol. 6, 458-466.
119. OLSVIK, O., WACHSMUTH, K., MORRIS, G. and FEELEAY, J.C. 1984. Genetic probing of Campylobacter jejuni for cholera toxin and Escherichia coli heat-labile enterotoxin. Lancet ii, 449.
120. OWEN, R.L., PIERCE, N.F., APPLE, R.T. and CRAY, W.C. 1986. M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J. Infect. Dis. 153, 1108-1118.
121. PANG, T., WONG, P.Y., PUTHUCHEARY, S.D., SIHOTANG, K. and CHANG, W.K. 1987. In-vitro and in-vivo studies of a cytotoxin from Campylobacter jejuni. J. Med. Microbiol. 23, 193-198.
122. PEI, Z. and BLASER, M.J. 1993. PEB1, the major cell-binding factor of Campylobacter jejuni, is a homolog of the binding component in gram-negative nutrient transport systems. J. Biol. Chem. 268, 18717-18725.
123. PENN, C.W. and LUKE, C.J. 1992. Bacterial flagellar diversity and significance in pathogenesis. FEMS Microbiol. Lett. 100, 331-336.
124. PEPE, J.C. and MILLER, V.L. 1993. Yersinia enterocolitica invasin: a primary role in the initiation of infection. Proc. Natl. Acad. Sci., USA 90, 6471-6477.
125. PEREZ-PEREZ, G.L., COHN, D.L., GUERRANT, R.L., PATTON, C.M., RELLER, L.B. and BLASER, M.J. 1989. Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in USA. J. Infect. Dis. 160, 460-468.
126. PEREZ-PEREZ, G.L., TAYLOR, D.N., ECHEVERRIA, P.D. and BLASER, M.J. 1992. Lack of evidence of enterotoxin involvement in pathogenesis of Campylobacter diarrhea, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 184-192, Am. Soc. Microbiol, Washington, DC.
127. PESCI, E.C., COTTLE, D.L. and PICKETT, C.L. 1994. Genetic, enzymatic, and pathogenic studies of the iron superoxide dismutase of Campylobacter jejuni. Infect. Immun. 62, 2687-2694.
128. PETERSON, M.C. 1994. Clinical aspects of Campylobacter jejuni infections in adults. West. J. Med. 161, 148-152.
129. PICKETT, C.L., AUFFENBERG, T., PESCI, E.C., SHEEN, V.L. and JUSUF, S.S.D. 1992. Iron acquisition and hemolysin production by Campylobacter jejuni. Infect. Immun. 60, 3872-3877.
130. PICKETT, C.L., COTTLE, D.L., PESCI, E.C. and BIKAH, G. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62, 1046-1051.
131. POLLA, B.S. 1988. A role for heat shock proteins in inflammation? Immunol. Today 9, 134-137.
132. POLOTSKY, Y., DRAGUNSKY, E. and KHAVKIN, T. 1994. Morphological evaluation of the pathogenesis of bacterial enteric infections. Crit. Rev. Microbiol. 20, 161-208.
133. PROBST, P., HERMANN, E., MEYER zum BUSCHENFELDE, K.-H. and FLEISCHER, B. 1993a. Identification of the Yersinia enterocolitica urease β subunit as a target antigen for human synovial T lymphocytes in reactive arthritis. Infect. Immun. 61, 4507-4509.
134. PROBST, P., HERMANN, E., MEYER zum BUSCHENFELDE, K.-H. and FLEISCHER, B. 1993b. Multiclonal synovial T cell response to Yersinia enterocolitica in reactive arthritis: the Yersinia 61-kDa heat-shock protein is not the major target antigen. J. Infect. Dis. 167, 385-391.
135. PURDY, D. and PARK, S.F. 1994. Cloning, nucleotide sequence and characterization of a gene encoding superoxide dismutase from Campylobacter jejuni and Campylobacter coli. Microbiology 140, 1203-1208.
136. PUTNAM, J.J. and ALLSHOUSE, I.E. 1994. Food consumption, prices and expenditures, 1970-93, p. 32. Statistical Bulletin #915, Economic Research Service, U.S. Dept. Agriculture.
137. REES, J.H., GREGSON, N.A., GRIFFITHS, P.I. and HUGHES, R.A.C. 1993. Campylobacter jejuni and Guillain-Barré syndrome. Quart. J. Med. 86, 623-634.
138. ROPPER, A.H. 1992. The Guillain-Barré syndrome. New Eng. J. Med. 326, 1130-1136.
139. RUBIN, D.H., KORNSTEIN, M.J. and ANDERSON, A.O. 1985. Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease. J. Virol. 53, 391-398.
140. RUIZ-PALACIOS, G. M. 1992. Pathogenesis of Campylobacter infection: in vitro models, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 158-159, Am. Soc. Microbiol, Washington, DC.
141. RUIZ-PALACIOS, G.M., CERVANTES, L.E., NEWBURG, D.S., LOPEZ-VIDAL, Y. and CALVA, J.J. 1992. In vitro models for studying Campylobacter infections, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 176-183, Am. Soc. Microbiol, Washington, DC.
142. RUIZ-PALACIOS, G.M., TORRES, J., TORRES, N.I., ESCAMILLA, E., RUIS-PALACIOS, B.R. and TAMAYO, J. 1983. Cholera-like enterotoxin produced Campylobacter jejuni. Characteristics and clinical significance. Lancet ii, 250-252.
143. RUSSELL, R.G. and BLAKE, D.C. 1994. Cell association and invasion of Caco-2 cells by Campylobacter jejuni. Infect. Immun. 62, 3773-3779.
144. SAHA, S.K. and SANYAL, S.C. 1990. Production and characterization of Campylobacter jejuni enterotoxin in a synthetic medium and its assay in rat ileal loops. FEMS Microbiol. Lett. 67, 333-338.
145. SAHA, S.K., SINGH, N.P. and SANYAL, S.C. 1988. Enterotoxigenicity of chicken isolates of Campylobacter jejuni in ligated ileal loops of rats. J. Med. Microbiol. 26, 87-91.
146. SALYERS, A.A. and WHITT, D.D. 1994. Bacterial pathogenesis: a molecular approach. ASM Press, Washington, DC.
147. SARTOR, R.B. 1994 Cytokines in intestinal inflammation: pathophysiological clinical considerations. Gastroenterology 106, 533-539.
148. h1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur. J. Immunol. 22, 2771-2776.
149. SCHLIEVERT, P.M. 1993. Role of superantigens in human disease. J. Infect. Dis. 167, 997-1002.
150. SCHULTZ, D.R. and ARNOLD, P.I. 1993. Heat shock (stress) proteins and autoimmunity in rheumatic diseases. Arth. Rheum. 22, 357-374.
151. SCHULTZ-KOOPS et al. 1993. Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect. Immun. 61, 2513-2519.
152. SCHULTZ-KOOPS, H., BURKHARDT, H., HEESEMANN, J., MARK, K. von der and EMMRICH, F. 1992. Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen. Infect. Immun. 60, 2153-2159.
153. SCOTT, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260, 496-497.
154. SISSONS, J.G.P. 1993. Superantigens and infectious disease. Lancet 341, 1627-1629.
155. SKIRROW, M.B. 1991. Epidemiology of Campylobacter enteritis. Int. J. Food Microbiol. 12, 9-16.
156. SKURNIK, M., BATSFORD, S., MERTZ, A., SCHILTZ, E. and TOIVANEN, P. 1993. The putative arthritogenic cationic 19-kilodalton antigen of Yersinia enterocolitica is a urease β-subunit. Infect. Immun. 61, 2498-2504.
157. SMITH, J.L. 1995. Arthritis, Guillain-Barré syndrome and other sequelae of Campylobacter jejuni enteritis. J. Food Prot. 58, 1153-1170.
158. SMITH, J.L. 1988. Heat-stable enterotoxins: properties, detection and assay. Develop. Ind. Microbio. 29, 275-286.
159. SMITH, J.L., PALUMBO, S.A. and WALLS, I. 1993. Relationship between foodborne bacterial pathogens and the reactive arthritides. J. Food Safety 13, 209-236.
160. SNELLER, M.C. and STROBER, W. 1986. M cells and host defense. J. Infect. Dis. 154, 737-741.
161. STERN, N.J. 1992. Reservoirs for Campylobacter jejuni and approaches for intervention in poultry, In Campylobacter jejuni: Current Status and Future Trends, (I. Nachamkin, M.J. Blaser and L.S. Tompkins, eds.) pp. 49-60, Am. Soc. Microbiol, Washington, DC.
162. STERN, N.J. and KAZMI, S.U. 1989. Campylobacter jejuni, In Foodborne Bacterial Pathogens, (M.P. Doyle, ed.) pp.71-110, Marcel Dekker, New York.
163. STERN, N.J., KAZMI, S.U., ROBERSON, B.S., ONO, K. and JUVEN, B.J. 1988. Response of Campylobacter jejuni to combinations of ferrous sulphate and cadmium chloride. J. Appl. Bacteriol. 64, 247-256.
164. STITES, D.P. and TERR, A.L. 1991. Basic and Clinical Immunology, 7th Ed. Appleton and Lange, Norwalk, CT.
165. STUART, P.M. and WOODWARD, J.G. 1992. Yersinia enterocolitica produces superantigenic activity. J. Immunol. 148, 225-233.
166. SUZUKI, S., KAWAGUCHI, M., MIZUNO, K., TAKAMA, K. and YUKI, N. 1994. Immunological properties and ganglioside recognition by Campylobacter jejuni-enterotoxin and cholera toxin. FEMS Immunol. Med. Microbiol. 8, 207-212.
167. SZYMANSKI, C.M., KING, M., HAARDT, M. and ARMSTRONG, G.D. 1995. Campylobacter jejuni motility and invasion of Caco-2 cells. Infect. Immun. 63, 4295-4300.
168. TAMM, A., TARKKANEN, A.-M., KORHONEN, T. K., KUUSELA, P., TOIVANEN, P. and SKURNIK, M. 1993. Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol. Microbiol. 10, 995-1011.
169. TAUB, D.D. and BLANK, K.J. 1993. Superantigens and microbial pathogenesis. Ann. Intern. Med. 119, 89-90.
170. TAUXE, R.V., HARGRETT-BEAN, N., PATTON, C.M. and WACHSMUTH, I.K. 1988. Campylobacter isolates in the United States, 1982-1986. Morb. Mort. Week. Rept. 37, No. SS-2, 1-13.
171. TAY, S.T., DEVI, S., PUTHUCHEARY, S.D. and KAUTNER, I.M. 1995. Detection of haemolytic activity of campylobacters by agarose haemolysis and microplate assay. J. Med. Microbiol. 42, 175-180.
172. TERTTI, R., SKURNIK, M., VARTIO, T. and KUUSELA, P. 1992. Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect. Immun. 60, 3021-3024.
173. TESH, V.L. and O'BRIEN, A.D. 1992. Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli. Microbial Pathogen. 12, 245-254.
174. TOIVANEN, P., TOIVANEN, A. and BRINES, R. 1994. When is an autoimmune disease not an autoimmune disease? Immunol. Today 15, 556-559.
175. UCHIYAMA, T., MIYOSHI-AKIYAMA, T., KATO, H., FUJIMAKI, W., IMANISHI, K. and YAN, X.-J. 1993. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol. 151, 4470-4413.
176. U.S. BUREAU OF THE CENSUS. 1992. Statistical abstracts of the United States: 1992 (112th Ed.) p. 132, Washington, DC.
177. WADSTROM, T., BALODA, S.B., KROVACEK, K., FARIS, A., BENGTSON, S. and WALDER, M. 1983. Swedish isolates of Campylobacter jejuni/coli do not produce cytotonic or cytotoxic enterotoxins. Lancet ii, 911.
178. WALKER, R.I., CALDWELL, M.B., LEE, E.C., GUERRY, P., TRUST, T.J. and M. RUIZ-PALACIOS, G. 1986. Pathophysiology of Campylobacter enteritis. Microbiol. Rev. 50, 81-94.
179. WALKER, R.I. and OWEN, R.L. 1990. Intestinal barriers to bacteria and their toxins. Ann. Rev. Med. 41, 393-400.
180. WALKER, R.I., SCHMAUDER-CHOCK, E.A., PARKER, J.L. and BURR, D. 1988. Selective association and transport of Campylobacter jejuni through M cells of rabbit Peyer's patches. Can. J. Microbiol. 34, 1142-1147.
181. WALSH, F.S. et al. 1991. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34, 43-51.
182. WASSEF, J.S., KEREN, D.F. and MAILLOUX, J.L. 1989. Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis. Infect. Immun. 57, 858-861.
183. + mutant of Campylobacter jejuni. Infect. Immun. 62, 3901-3906.
184. WASSENAAR, T.M., BLEUMINK-PLUYM, N.M. and ZEIJST, B.A.M. van der 1991. Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J. 10, 2055-2061.
185. WASSENAAR, T.M., ZEIJST, B.A.M. van der, AYLING, R. and NEWELL, D.G. 1993. Colonization of chicks by motility mutants of Campylobacter jejuni demonstrates the importance of flagellin A expression. J. Gen. Microbiol. 139, 1171-1175.
186. WILLISON, H.J. and KENNEDY, P.G.E. 1993. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J. Neuroimmunol. 46, 105-112.
187. WILLISON, H.J., VEITCH, J., PATERSON, G. and KENNEDY, P.G.E. 1993. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psych. 56, 204-206.
188. WOLF, J.L., KAUFFMAN, R.S., FINBERG, R., DAMBRAUSKAS, R., FIELDS, B.N. and TRIER, J.S. 1983. Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology 85, 291-300.
189. WOLF, J.L. et al. 1981. Intestinal M cells: a pathway for entry of reovirus into the host. Science 212, 471-472.
190. WONG, P.Y., PUTHUCHEARY, S.D. and PANG, T. 1983. Demonstration of a cytotoxin from Campylobacter jejuni. J. Clin. Pathol. 36, 1237-1240.
191. WOOLRIDGE, K.G., WILLIAMS, P.H. and KETLEY, J.M. 1994. Iron-responsive genetic regulation in Campylobacter jejuni: cloning and characterization of a fur homolog. J. Bacteriol. 176, 5852-5856.
192. WU, Y.L., LEE, L.H., ROLLINS, D.M. and CHING, W.M. 1994. Heat shock-and alkaline pH-induced proteins of Campylobacter jejuni: characterization and immunological properties. Infect. Immun. 62, 4256-4260.
193. WULFFEN, H. von, HARTARD, C. and SCHAREIN, E. 1994. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome. J. Infect. Dis. 170, 828-833.
194. YAO, R., BURR, D.H., DOIG, P., TRUST, T.J., NIU, H. and GUERRY, P. 1994 Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol. Microbiol. 14, 883-893.
195. YOSHINO, K. et al. 1994. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis. FEBS Lett. 356, 141-144.
196. YUKI, N., SATO, S., TSUJI, S., OHSAWA, T. and MIYATAKE, T. 1993. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurobiology 43, 414-417.
197. YUKI, N. et al. 1994a. Penner's serotype of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62, 2101-2103.
198. YUKI, N. et al. 1994b. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36, 791-793.
199. ZUMLA, A. 1992. Superantigens, T cells, and microbes. Clin. Infect. Dis. 15, 313-320.